.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
McKinsey
Healthtrust
US Army
Julphar
US Department of Justice
AstraZeneca
Argus Health
Novartis

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072641

« Back to Dashboard

NDA 072641 describes CLOTRIMAZOLE, which is a drug marketed by Fougera Pharms, Glenmark Pharms, Taro, Actavis Mid Atlantic, Teva, Paddock Llc, and West-ward Pharms Int, and is included in fifteen NDAs. It is available from nineteen suppliers. Additional details are available on the CLOTRIMAZOLE profile page.

The generic ingredient in CLOTRIMAZOLE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.

Summary for 072641

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 072641

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOTRIMAZOLE clotrimazole CREAM;VAGINAL 072641 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-2003 51672-2003-6 1 TUBE in 1 CARTON (51672-2003-6) > 45 g in 1 TUBE
CLOTRIMAZOLE clotrimazole CREAM;VAGINAL 072641 ANDA REMEDYREPACK INC. 61786-091 61786-091-46 45 g in 1 TUBE (61786-091-46)

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;VAGINALStrength1%
Approval Date:Dec 4, 1995TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Cipla
Johnson and Johnson
Healthtrust
Chinese Patent Office
Dow
Fish and Richardson
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot